BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8745969)

  • 1. [Continuous administration of mivacurium for short procedures. Delayed onset and recovery from neuromuscular blockade].
    Pellissier D; Bruder N; Mokart D; Quilichini D; Camatte S; Blache JL; François G
    Ann Fr Anesth Reanim; 1995; 14(6):467-71. PubMed ID: 8745969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged mivacurium infusion in young and elderly adults.
    Goudsouzian N; Chakravorti S; Denman W; Schwartz A; Yang HS; Cook DR
    Can J Anaesth; 1997 Sep; 44(9):955-62. PubMed ID: 9305559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of the monitoring of curarisation during prolonged mivacurium induced neuromuscular block].
    Avargues P; Cros AM; Dardel E; Darriet M; Biteau N
    Ann Fr Anesth Reanim; 1995; 14(6):511-3. PubMed ID: 8745977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mivacurium chloride administration by infusion.
    Apfelbaum JL
    Acta Anaesthesiol Scand Suppl; 1995; 106():55-7. PubMed ID: 8533547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prolonged neuromuscular block after mivacurium injection].
    Viggiano M; Soler C; Dumont JC; Pellissier D; François G
    Ann Fr Anesth Reanim; 1995; 14(6):502-4. PubMed ID: 8745974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prolonged neuromuscular block after administration of mivacurium caused by plasma psueudocholinesterase deficiency].
    Kaiser E; Petit D; Quinot JF; Suppini A; Sallaberry M
    Ann Fr Anesth Reanim; 1995; 14(6):505-7. PubMed ID: 8745975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Onset and duration of mivacurium-induced neuromuscular block in patients with Duchenne muscular dystrophy.
    Schmidt J; Muenster T; Wick S; Forst J; Schmitt HJ
    Br J Anaesth; 2005 Dec; 95(6):769-72. PubMed ID: 16183677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prolonged neuromuscular block induced by mivacurium in a patient treated with cyclophosphamide].
    Vigouroux D; Voltaire L
    Ann Fr Anesth Reanim; 1995; 14(6):508-10. PubMed ID: 8745976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased mivacurium requirements and delayed neuromuscular recovery during sevoflurane anesthesia in children and adults.
    Bevan JC; Reimer EJ; Smith MF; Scheepers L deV ; Bridge HS; Martin GR; Bevan DR
    Anesth Analg; 1998 Oct; 87(4):772-8. PubMed ID: 9768768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuromuscular and clinical effects of mivacurium chloride in healthy adult patients during nitrous oxide-enflurane anaesthesia.
    Goldhill DR; Whitehead JP; Emmott RS; Griffith AP; Bracey BJ; Flynn PJ
    Br J Anaesth; 1991 Sep; 67(3):289-95. PubMed ID: 1832920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). A short-acting nondepolarizing ester neuromuscular blocking drug.
    Savarese JJ; Ali HH; Basta SJ; Embree PB; Scott RP; Sunder N; Weakly JN; Wastila WB; el-Sayad HA
    Anesthesiology; 1988 May; 68(5):723-32. PubMed ID: 2967039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Edrophonium requirements for reversal of deep neuromuscular block following infusion of mivacurium.
    Miller DR; Bryson G; Martineau RJ; Kitts JB; Curran M; Bragg P; Watson JB; Hull K; Lindsay P
    Can J Anaesth; 1995 Nov; 42(11):996-1002. PubMed ID: 8590511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamics of mivacurium in children, using a computer-controlled infusion.
    Meretoja OA; Olkkola KT
    Br J Anaesth; 1993 Aug; 71(2):232-7. PubMed ID: 8123398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamics of mivacurium in infants.
    Meretoja OA; Taivainen T; Wirtavuori K; Olkkola KT
    Br J Anaesth; 1994 Oct; 73(4):490-3. PubMed ID: 7695717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between mivacurium, rocuronium, and vecuronium during general anesthesia.
    Kim DW; Joshi GP; White PF; Johnson ER
    Anesth Analg; 1996 Oct; 83(4):818-22. PubMed ID: 8831328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous versus edrophonium-induced recovery from paralysis with mivacurium.
    Brandom BW; Taiwo OO; Woelfel SK; Schön H; Gronert BJ; Cook DR
    Anesth Analg; 1996 May; 82(5):999-1002. PubMed ID: 8610913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The duration of action of mivacurium is prolonged if preceded by atracurium or vecuronium.
    Rautoma P; Meretoja OA; Erkola O; Kalli I
    Acta Anaesthesiol Scand; 1995 Oct; 39(7):912-5. PubMed ID: 8848891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of mivacurium-induced neuromuscular blockade in humans. Edrophonium dose requirements at threshold train-of-four count of 4.
    Kopman AF; Mallhi MU; Justo MD; Rodricks P; Neuman GG
    Anesthesiology; 1994 Dec; 81(6):1394-400. PubMed ID: 7992908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuromuscular recovery following mivacurium is predictable in patients with severe systemic disease prognoses].
    Blobner M; Busley R; Mann R; Jelen-Esselborn S; Kochs E
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Oct; 34(10):638-41. PubMed ID: 10548961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuromuscular and cardiovascular effect of mivacurium in anesthesia induction in patients with renal failure].
    Blobner M; Jelen-Esselborn S; Mann R; Kling M; Schneider G; Schneck HJ; Kochs E
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Feb; 31(1):15-21. PubMed ID: 8868527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.